December 28, 2009 - The Society of Nuclear Medicine (SNM) said in a recent statement it is pleased that the U.S. Congress has passed a fix to freeze the conversion factor at the 2009 rate for physicians, which will ensure that millions of patients continue to receive medical coverage for critical diagnostic imaging tests and therapeutics. However, SNM cautions that a long-term solution is necessary to address this ongoing problem.

"We urge Congress to take action now to implement a long-term formula that adequately addresses the level of demand—and actual cost of providing these services," said Michael M. Graham, Ph.D., M.D., president of SNM. "This is a critical issue facing the medical community, and we need to continue to work together to protect the patients we serve."

On Dec. 16, the U.S. House of Representatives passed H.R. 3326, which delays cuts to reimbursement rates for physicians, which have been looming on the horizon and would affect nearly one-third of the American public who are eligible for coverage through Medicare or Medicaid, if implemented. The Senate approved the measure on Dec. 19. Significant cuts in the reimbursement rates for physicians will be postponed until March 1, 2010. In the short-term, the fix to the SGR will protect cuts to medical care. If a long-term fix is not approved, Medicare funding could be cut by more than 21 percent next year.

"At this time, the term ‘SGR fix’ is really a misnomer," said Graham. "A two-month patch is not a resolution to an ongoing issue that has been affecting patients and the medical community. While this is a good temporary measure, we hope that the Senate will take swift action to establish a permanent solution." After the temporary fix expires, physicians would once again face severe cuts in the level of reimbursement they receive for caring for Medicare patients. Previously, Congress has failed to approve a permanent fix to the SGR, instead passing a series of one-year patches to prevent proposed cuts.

"While patches have worked in the short-term, they do not really address the chronic issue," Graham said. Cumulatively, the effect is that medical reimbursement rates have not kept pace with inflation—even while the cost of health care escalates."

SNM continues to work with members of Congress and other medical societies to ensure that coverage remains a priority on the national health care agenda.

For more information: www.snm.org


Related Content

Feature | Artificial Intelligence

For the past decade, artificial intelligence's (AI) potential in healthcare has been synonymous with speed. In medical ...

Time February 16, 2026
arrow
News | ARRS

Feb. 11, 2026 —The American Roentgen Ray Society (ARRS) has announced the following radiologists, as well as their ...

Time February 13, 2026
arrow
News | Radiology Business

Feb. 3, 2026 — RadNet, Inc., a provider of high-quality, cost-effective outpatient diagnostic imaging services and ...

Time February 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 6, 2026 — A state-of-the-art intraoperative MRI (iMRI) has arrived at the University of Chicago Medicine, one of ...

Time February 06, 2026
arrow
News | Computed Tomography (CT)

Feb. 4, 2026 — A new review published in the American Journal of Roentgenology (AJR) finds that advances in CT ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Computed Tomography (CT)

Jan. 21, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) cleared the industry's first ...

Time January 23, 2026
arrow
Subscribe Now